Total Payments
$1.2M
2024 Payments
$194,719
Companies
54
Transactions
2,994
Medicare Patients
9,732
Medicare Billing
$1.7M
Payment Breakdown by Category
Other$908,633 (78.6%)
Consulting$90,729 (7.9%)
Travel$81,120 (7.0%)
Food & Beverage$54,241 (4.7%)
Research$19,291 (1.7%)
Education$1,358 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $766,394 | 332 | 66.3% |
| Honoraria | $100,039 | 51 | 8.7% |
| Consulting Fee | $90,729 | 39 | 7.9% |
| Travel and Lodging | $81,120 | 255 | 7.0% |
| Food and Beverage | $54,241 | 2,265 | 4.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $35,000 | 12 | 3.0% |
| Unspecified | $19,291 | 6 | 1.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $7,200 | 2 | 0.6% |
| Education | $1,358 | 32 | 0.1% |
Payments by Type
General
$1.1M
2,988 transactions
Research
$19,291
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $156,504 | 209 | $0 (2024) |
| Lilly USA, LLC | $152,380 | 236 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $148,266 | 117 | $0 (2022) |
| Galderma Laboratories, L.P. | $129,766 | 267 | $0 (2024) |
| PFIZER INC. | $108,710 | 210 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $82,504 | 185 | $0 (2024) |
| Janssen Biotech, Inc. | $68,410 | 391 | $0 (2024) |
| Incyte Corporation | $65,898 | 113 | $0 (2024) |
| Dermavant Sciences, Inc. | $40,775 | 83 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $37,298 | 96 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $194,719 | 461 | Galderma Laboratories, L.P. ($38,515) |
| 2023 | $210,866 | 516 | Sun Pharmaceutical Industries Inc. ($46,165) |
| 2022 | $123,211 | 428 | Lilly USA, LLC ($27,475) |
| 2021 | $82,496 | 261 | SUN PHARMACEUTICAL INDUSTRIES INC. ($35,008) |
| 2020 | $55,976 | 256 | Janssen Scientific Affairs, LLC ($12,475) |
| 2019 | $170,241 | 348 | Janssen Scientific Affairs, LLC ($57,415) |
| 2018 | $192,910 | 378 | Janssen Scientific Affairs, LLC ($41,987) |
| 2017 | $124,952 | 346 | Novartis Pharmaceuticals Corporation ($24,385) |
All Payment Transactions
2,994 individual payment records from CMS Open Payments — Page 1 of 120
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Dermatology | ||||||
| 12/20/2024 | PFIZER INC. | CIBINQO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,275.00 | General |
| Category: Inflammation & Immunology | ||||||
| 12/19/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: Inflammation & Immunology | ||||||
| 12/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Immunology | ||||||
| 12/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.86 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $22.79 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: DERMATOLOGY | ||||||
| 12/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.59 | General |
| 12/04/2024 | Almirall LLC | Seysara (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TRALOKINUMAB MONOTHERAPY FOR MODERATE TO SEVERE ATOPIC DERMATITIS - ECZTRA 1 ECZEMA TRALOKINUMAB TRIAL NO. 1 ECZTRA 1 | LEO Pharma AS | $13,624 | 5 |
| A MULTICENTER RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY COMPARING THE EFFICACY AND SAFETY OF LY2439821 TO ETANERCEPT AND PLACEBO IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS | Eli Lilly and Company | $5,667 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,282 | 11,750 | $1.2M | $620,219 |
| 2022 | 25 | 2,455 | 7,641 | $753,786 | $215,810 |
| 2021 | 22 | 2,491 | 9,293 | $1.5M | $627,174 |
| 2020 | 24 | 2,504 | 12,585 | $900,326 | $205,300 |
Total Patients
9,732
Total Services
41,269
Medicare Billing
$1.7M
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3245 | Injection, tildrakizumab, 1 mg | Office | 2023 | 12 | 3,800 | $553,584 | $418,060 | 75.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 558 | 1,017 | $179,946 | $61,477 | 34.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 292 | 384 | $86,231 | $28,822 | 33.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 339 | 524 | $69,314 | $17,850 | 25.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 183 | 241 | $48,246 | $13,821 | 28.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 29 | 35 | $27,342 | $10,728 | 39.2% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 42 | 46 | $25,332 | $9,328 | 36.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 42 | 53 | $25,536 | $8,291 | 32.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 257 | 1,527 | $20,162 | $7,526 | 37.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 141 | 188 | $20,811 | $7,282 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 92 | $23,035 | $6,603 | 28.7% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 23 | 31 | $16,353 | $5,977 | 36.6% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 15 | 3,200 | $10,564 | $4,152 | 39.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 15 | 19 | $10,393 | $3,910 | 37.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 27 | 33 | $10,942 | $3,868 | 35.3% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 17 | 20 | $10,048 | $3,386 | 33.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $9,877 | $3,032 | 30.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 29 | 44 | $4,335 | $1,633 | 37.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 18 | 19 | $4,709 | $1,602 | 34.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 122 | $3,373 | $1,119 | 33.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 22 | 29 | $3,250 | $987.34 | 30.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $1,839 | $578.28 | 31.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 46 | 268 | $568.16 | $188.29 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 561 | 977 | $194,091 | $57,718 | 29.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 303 | 421 | $117,935 | $32,626 | 27.7% |
About Dr. Daniel Carrasco, MD
Dr. Daniel Carrasco, MD is a Dermatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558345793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Carrasco, MD has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $194,719 received in 2024. These payments were reported across 2,994 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($766,394).
As a Medicare-enrolled provider, Carrasco has provided services to 9,732 Medicare beneficiaries, totaling 41,269 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Austin, TX
- Active Since 12/01/2005
- Last Updated 01/19/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1558345793
Products in Payments
- TALTZ (Drug) $152,076
- TREMFYA (Drug) $115,829
- Tremfya (Drug) $99,519
- COSENTYX (Biological) $79,284
- ILUMYA (Biological) $73,562
- OPZELURA (Drug) $60,818
- CIBINQO (Drug) $59,785
- EUCRISA (Drug) $47,778
- VTAMA (Drug) $40,775
- AKLIEF (Drug) $40,456
- Winlevi (Drug) $25,993
- HALOG (Drug) $23,678
- ORACEA (Drug) $20,905
- EPSOLAY (Drug) $18,391
- SILIQ (Drug) $18,280
- QBREXZA (Drug) $17,481
- SOOLANTRA (Drug) $16,247
- Bimzelx (Biological) $11,469
- DUPIXENT (Biological) $10,320
- ABSORICA (Drug) $9,749
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Austin
Dr. Edward Lain, M.d, M.D
Dermatology — Payments: $2.3M
Dermatology $2.3M
Dale Schaefer, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Janet Dubois, M.d, M.D
Dermatology — Payments: $1.1M
Dermatology $1.1M
Ms. Heidi Prather, M.d, M.D
Dermatology — Payments: $530,857
Dermatology $530,857
Daniel Friedmann, M.d, M.D
Dermatology — Payments: $231,608
Dermatology $231,608
Dr. Jennifer Gordon, Md, MD
Dermatology — Payments: $161,696
Dermatology $161,696